RxDoctor Payments Data

Mahjabeen Islam, MD

Family Medicine · Maumee, OHNPI 1770606063

Payments from drug & device makers

$3,035in general payments, 2019–2025

Across 187 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orexo US, Inc.$502
  • AbbVie$498
  • AstraZeneca$429
  • Novo Nordisk$349
  • Merck$203
  • GSK$148
  • plus $906 from 13 others

What the payments were for

  • Food & beverage$3,020100%
  • Education$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,035 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$30,178
Medicare patients
52
Services billed
454

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl149$26,282
FarxigaDapagliflozin Propanediol18$18,010
EliquisApixaban11$14,455
OzempicSemaglutide11$12,340
Tresiba Flextouch U-200Insulin Degludec11$7,803
XareltoRivaroxaban12$6,164
Buprenorphine13$6,113
Spiriva RespimatTiotropium Bromide12$5,971
SuboxoneBuprenorphine Hcl/Naloxone Hcl11$4,858
Fentanyl24$2,974
SynthroidLevothyroxine Sodium26$1,697
Atorvastatin Calcium159$1,536
Gabapentin82$1,522
Potassium Chloride45$1,003
Metformin Hcl ErMetformin Hcl115$918

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$429$18,01018 claims
PfizerEliquis$112$14,45511 claims
Novo NordiskOzempic$349$12,34011 claims
Boehringer IngelheimSpiriva Respimat$66$5,97112 claims
Indivior Inc.Suboxone$88$4,85811 claims
AbbVieSynthroid$498$1,69726 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Maumee

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →